Ernexa Therapeutics Inc. — Director's Dealing 2021

Mar 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NTN BUZZTIME INC (NTN)
CIK: 0000748592
Period of Report: 2021-03-19

Reporting Person: Wolff Allen (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-19	Common Stock	F	207	$3.53	Disposed	138464	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2100	Indirect
Common Stock	2100	Indirect

Footnotes

F1: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units. The number of shares to be withheld was determinable on March 19, 2021. No shares were sold in connection with this transaction.

F2: As custodian of Child 1.

F3: As custodian of Child 2.